GOG 0281

Trial Description: 
A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients With Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal Cancer
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Ovarian
Trial Status: 
Closed to Recruitment
Contact person: